Compare Abbott India with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ALEMBIC LTD - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ALEMBIC LTD ABBOTT INDIA/
ALEMBIC LTD
 
P/E (TTM) x 55.2 44.6 123.8% View Chart
P/BV x 16.4 1.8 898.0% View Chart
Dividend Yield % 0.4 0.6 75.1%  

Financials

 ABBOTT INDIA   ALEMBIC LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
ALEMBIC LTD
Mar-18
ABBOTT INDIA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs8,83472 12,269.6%   
Low Rs5,45834 16,098.8%   
Sales per share (Unadj.) Rs1,731.14.7 36,827.4%  
Earnings per share (Unadj.) Rs211.96.1 3,472.0%  
Cash flow per share (Unadj.) Rs219.96.2 3,520.8%  
Dividends per share (Unadj.) Rs65.000.20 32,500.0%  
Dividend yield (eoy) %0.90.4 240.8%  
Book value per share (Unadj.) Rs945.240.7 2,324.6%  
Shares outstanding (eoy) m21.25267.03 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.111.3 36.6%   
Avg P/E ratio x33.78.7 388.7%  
P/CF ratio (eoy) x32.58.5 383.3%  
Price / Book Value ratio x7.61.3 580.5%  
Dividend payout %30.73.3 936.0%   
Avg Mkt Cap Rs m151,84814,139 1,073.9%   
No. of employees `0003.5NA-   
Total wages/salary Rs m4,356207 2,100.2%   
Avg. sales/employee Rs Th10,555.5NM-  
Avg. wages/employee Rs Th1,249.9NM-  
Avg. net profit/employee Rs Th1,292.2NM-  
INCOME DATA
Net Sales Rs m36,7861,255 2,930.7%  
Other income Rs m1,133370 306.0%   
Total revenues Rs m37,9191,625 2,332.9%   
Gross profit Rs m6,047111 5,443.1%  
Depreciation Rs m16938 447.6%   
Interest Rs m232 1,323.5%   
Profit before tax Rs m6,989442 1,581.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,48524 10,376.6%   
Profit after tax Rs m4,5031,630 276.3%  
Gross profit margin %16.48.9 185.7%  
Effective tax rate %35.65.4 656.0%   
Net profit margin %12.2129.8 9.4%  
BALANCE SHEET DATA
Current assets Rs m27,6101,867 1,478.8%   
Current liabilities Rs m8,569591 1,449.4%   
Net working cap to sales %51.8101.6 50.9%  
Current ratio x3.23.2 102.0%  
Inventory Days Days6094 63.9%  
Debtors Days Days2774 37.3%  
Net fixed assets Rs m1,0571,791 59.0%   
Share capital Rs m213534 39.8%   
"Free" reserves Rs m19,87310,324 192.5%   
Net worth Rs m20,08610,858 185.0%   
Long term debt Rs m041 0.0%   
Total assets Rs m29,40911,591 253.7%  
Interest coverage x311.6260.9 119.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.1 1,155.0%   
Return on assets %15.414.1 109.3%  
Return on equity %22.415.0 149.4%  
Return on capital %34.915.2 229.8%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m36919 1,901.9%   
Fx outflow Rs m4,918264 1,864.3%   
Net fx Rs m-4,549-244 1,861.3%   
CASH FLOW
From Operations Rs m4,991236 2,116.8%  
From Investments Rs m-2,570-224 1,147.3%  
From Financial Activity Rs m-1,428-27 5,368.4%  
Net Cashflow Rs m993-15 -6,711.5%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.2 3,950.0%  
FIIs % 0.1 9.7 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 26.1 65.5%  
Shareholders   18,270 54,701 33.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 1,028 Points; Oil & Gas, FMCG and Metal Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note, tracking global cues.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Mar 31, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS